Literature DB >> 29430041

Doubly robust nonparametric inference on the average treatment effect.

D Benkeser1, M Carone2, M J Van Der Laan3, P B Gilbert4.   

Abstract

Doubly robust estimators are widely used to draw inference about the average effect of a treatment. Such estimators are consistent for the effect of interest if either one of two nuisance parameters is consistently estimated. However, if flexible, data-adaptive estimators of these nuisance parameters are used, double robustness does not readily extend to inference. We present a general theoretical study of the behaviour of doubly robust estimators of an average treatment effect when one of the nuisance parameters is inconsistently estimated. We contrast different methods for constructing such estimators and investigate the extent to which they may be modified to also allow doubly robust inference. We find that while targeted minimum loss-based estimation can be used to solve this problem very naturally, common alternative frameworks appear to be inappropriate for this purpose. We provide a theoretical study and a numerical evaluation of the alternatives considered. Our simulations highlight the need for and usefulness of these approaches in practice, while our theoretical developments have broad implications for the construction of estimators that permit doubly robust inference in other problems.

Entities:  

Keywords:  Adaptive estimation; Doubly robust estimation; Efficient influence function; Targeted minimum loss-based estimation

Year:  2017        PMID: 29430041      PMCID: PMC5793673          DOI: 10.1093/biomet/asx053

Source DB:  PubMed          Journal:  Biometrika        ISSN: 0006-3444            Impact factor:   2.445


  6 in total

1.  The relative performance of targeted maximum likelihood estimators.

Authors:  Kristin E Porter; Susan Gruber; Mark J van der Laan; Jasjeet S Sekhon
Journal:  Int J Biostat       Date:  2011-08-17       Impact factor: 0.968

2.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

3.  Comment: Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data.

Authors:  Anastasios A Tsiatis; Marie Davidian
Journal:  Stat Sci       Date:  2007       Impact factor: 2.901

4.  Targeted estimation of nuisance parameters to obtain valid statistical inference.

Authors:  Mark J van der Laan
Journal:  Int J Biostat       Date:  2014       Impact factor: 0.968

5.  Data-Adaptive Bias-Reduced Doubly Robust Estimation.

Authors:  Karel Vermeulen; Stijn Vansteelandt
Journal:  Int J Biostat       Date:  2016-05-01       Impact factor: 0.968

6.  One-Step Targeted Minimum Loss-based Estimation Based on Universal Least Favorable One-Dimensional Submodels.

Authors:  Mark van der Laan; Susan Gruber
Journal:  Int J Biostat       Date:  2016-05-01       Impact factor: 0.968

  6 in total
  17 in total

1.  Efficient augmentation and relaxation learning for individualized treatment rules using observational data.

Authors:  Ying-Qi Zhao; Eric B Laber; Yang Ning; Sumona Saha; Bruce E Sands
Journal:  J Mach Learn Res       Date:  2019       Impact factor: 3.654

2.  In Pursuit of Evidence in Air Pollution Epidemiology: The Role of Causally Driven Data Science.

Authors:  Marco Carone; Francesca Dominici; Lianne Sheppard
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

3.  Complier stochastic direct effects: identification and robust estimation.

Authors:  Kara E Rudolph; Oleg Sofrygin; Mark J van der Laan
Journal:  J Am Stat Assoc       Date:  2020-01-23       Impact factor: 5.033

4.  Accounting for motion in resting-state fMRI: What part of the spectrum are we characterizing in autism spectrum disorder?

Authors:  Mary Beth Nebel; Daniel E Lidstone; Liwei Wang; David Benkeser; Stewart H Mostofsky; Benjamin B Risk
Journal:  Neuroimage       Date:  2022-05-10       Impact factor: 7.400

5.  Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens.

Authors:  R R Kempker; L Mikiashvili; Y Zhao; D Benkeser; K Barbakadze; N Bablishvili; Z Avaliani; C A Peloquin; H M Blumberg; M Kipiani
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

6.  Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis.

Authors:  Arman Alam Siddique; Mireille E Schnitzer; Asma Bahamyirou; Guanbo Wang; Timothy H Holtz; Giovanni B Migliori; Giovanni Sotgiu; Neel R Gandhi; Mario H Vargas; Dick Menzies; Andrea Benedetti
Journal:  Stat Methods Med Res       Date:  2018-10-31       Impact factor: 3.021

7.  Thirteen Questions About Using Machine Learning in Causal Research (You Won't Believe the Answer to Number 10!).

Authors:  Stephen J Mooney; Alexander P Keil; Daniel J Westreich
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

8.  Causal inference in high dimensions: A marriage between Bayesian modeling and good frequentist properties.

Authors:  Joseph Antonelli; Georgia Papadogeorgou; Francesca Dominici
Journal:  Biometrics       Date:  2020-12-31       Impact factor: 2.571

9.  Far from MCAR: Obtaining Population-level Estimates of HIV Viral Suppression.

Authors:  Laura B Balzer; James Ayieko; Dalsone Kwarisiima; Gabriel Chamie; Edwin D Charlebois; Joshua Schwab; Mark J van der Laan; Moses R Kamya; Diane V Havlir; Maya L Petersen
Journal:  Epidemiology       Date:  2020-09       Impact factor: 4.860

10.  Schistosoma mansoni Infection Is Associated With a Higher Probability of Tuberculosis Disease in HIV-Infected Adults in Kenya.

Authors:  Taryn A McLaughlin; Azhar Nizam; Felix Odhiambo Hayara; Gregory Sadat Ouma; Angela Campbell; Jeremiah Khayumbi; Joshua Ongalo; Samuel Gurrion Ouma; N Sarita Shah; John D Altman; Deepak Kaushal; Jyothi Rengarajan; Joel D Ernst; Henry M Blumberg; Lance A Waller; Neel R Gandhi; Cheryl L Day; David Benkeser
Journal:  J Acquir Immune Defic Syndr       Date:  2021-02-01       Impact factor: 3.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.